Revista do Instituto de Medicina Tropical de São Paulo (Sep 2020)

Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series

  • Hareton Teixeira Vechi,
  • Lucas Rodrigues Maia,
  • Manoella do Monte Alves

DOI
https://doi.org/10.1590/s1678-9946202062063
Journal volume & issue
Vol. 62

Abstract

Read online

ABSTRACT In late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as the cause of a cluster of pneumonia cases in China, and the corresponding disease was designated as Coronavirus Disease 2019 (COVID-19), spreading quickly around the world resulting in a pandemic. COVID-19 is associated with a set of coagulation abnormalities that increase the risk of thromboembolic events, especially in patients with severe/critical disease. We describe a series of five cases of mild COVID-19, treated in an outpatient clinic, which, after an apparent clinical improvement, developed acute pulmonary embolism (APE) between the third and the fourth week after the onset of symptoms, when they are mostly related to acute illness disappearance. Thromboembolic events are also a potential complication of mild COVID-19 and can manifest later in the disease course. This finding raises discussion about the prevention of thromboembolic events in selected group of patients with mild COVID-19.

Keywords